Try it
Microbiology · Bacteriology: Stenotrophomonas maltophilia treatment
Sample itemA ventilated ICU patient treated with meropenem for 10 days develops new pneumonia. Sputum grows an oxidase-negative, non-fermenting Gram-negative bacillus that is resistant to meropenem. Which drug is a first-line choice for this organism?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Trimethoprim-sulfamethoxazole
Stenotrophomonas maltophilia is intrinsically resistant to carbapenems because of a chromosomal metallo-beta-lactamase, and it also resists aztreonam and aminoglycosides. Trimethoprim-sulfamethoxazole is the drug of choice, and carbapenem exposure is a recognised risk factor.
Option by option
A. Imipenem-cilastatin
Imipenem is hydrolysed by the organism's intrinsic metallo-beta-lactamase.
B. Gentamicin
Aminoglycosides are poorly active because of low permeability and efflux.
C. Aztreonam
Aztreonam is inactivated by another chromosomal beta-lactamase and is not effective.
D. Trimethoprim-sulfamethoxazole (correct)
Correct. This combination is the first-line agent for the organism.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Microbiology questions
- BacteriologyA patient has profuse painless watery 'rice-water' stools and rapid dehydration. The cau…
- Culture mediaThayer–Martin medium is used selectively to isolate which organism?
- Immunology and serologyWhich of the following is a non-treponemal test for syphilis?
- BacteriologyAlbert's stain is used to demonstrate which of the following?